| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $90.78 | $633,916.74 | -19.2% | +16.0% | +9.5% | |
| Dec 2, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 4,376 | $6.18 | $27,065.16 | -0.4% | +27.0% | -73.2% | |
| Dec 2, 2024 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 5,497 | $6.19 | $34,006.23 | -0.7% | +27.0% | -73.2% | |
| Dec 2, 2024 | IART Integra Lifesciences Holdings Corp | McBreen Michael J.71 | EVP &President, Css | Sell | 1,700 | $24.16 | $41,063.50 | -2.9% | -8.5% | -46.5% | |
| Dec 2, 2024 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | Cbo And CLO | Sell | 2,492 | $85.89 | $214,037.88 | -6.6% | +24.1% | +106.9% | |
| Dec 2, 2024 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 2,500 | $87.00 | $217,501.50 | -100% | -5.5% | +6.1% | ||
| Dec 2, 2024 | BRKR Bruker Corp | Packer Richard A49 | Director | Sell | 3,350 | $57.82 | $193,682.60 | -4.0% | -19.9% | -19.0% | |
| Dec 2, 2024 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 12,000 | $162.91 | $1,954,934.51 | -3.6% | -12.1% | -8.9% | |
| Dec 2, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $244.49 | $146,696.56 | -0.2% | +16.8% | +17.5% | |
| Dec 2, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 1,084 | $86.40 | $93,657.60 | -4.9% | -18.6% | +66.5% | |
| Dec 2, 2024 | IRMD Iradimed Corp | Glenn John | Chief Financial Officer | Sell | 2,500 | $54.18 | $135,449.25 | -36.3% | -1.0% | +71.0% | |
| Dec 2, 2024 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 74 | $248.91 | $18,419.34 | -0.8% | -4.8% | +2.4% | |
| Dec 2, 2024 | PEN Penumbra Inc | Shiu Lambert | Chief Accounting Officer | Sell | 2,452 | $242.68 | $595,051.42 | -5.7% | +16.8% | +17.5% | |
| Nov 29, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 376 | $539.00 | $202,664.00 | -3.3% | +4.0% | +5.8% | |
| Nov 29, 2024 | ISRG Intuitive Surgical Inc | Samath Jamie62 | CFO And Head Of Business Techn | Sell | 188 | $539.00 | $101,332.00 | -1.1% | +4.0% | +5.8% | |
| Nov 29, 2024 | INCY Incyte Corp | Iyengar Vijay K62 | EVP, Gmapps | Sell | 6,043 | $75.38 | $455,543.71 | -8.3% | -1.9% | +40.0% | |
| Nov 29, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 3,105 | $46.08 | $143,078.40 | -6.8% | -39.8% | -75.6% | |
| Nov 29, 2024 | SGHT Sight Sciences, Inc. | Raheja Manohar K.73 | EVP, Research &Development | Buy | 4,624 | $3.99 | $18,440.51 | +4.7% | -33.8% | +109.5% | |
| Nov 27, 2024 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 1,430 | $158.00 | $225,936.28 | -100% | -3.7% | -7.1% | |
| Nov 27, 2024 | MODD Modular Medical, Inc. | Manchester Management Co LLC | 10% Owner, Director By Deputization | Buy | 100,000 | $1.69 | $168,950.00 | +69.1% | -41.4% | -76.0% | |
| Nov 27, 2024 | BSX Boston Scientific Corp | Woodworth Emily53 | SVP, Global Controller And CAO | Sell | 1,336 | $90.65 | $121,105.19 | -31.1% | +11.0% | +11.9% | |
| Nov 27, 2024 | ICUI Icu Medical Inc/de | Greenberg David C.66 | Director | Sell | 972 | $158.11 | $153,683.21 | -16.2% | -3.7% | -7.1% | |
| Nov 27, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 26,420 | $97.83 | $2,584,637.91 | -3.5% | -35.5% | -67.4% | |
| Nov 27, 2024 | IDXX Idexx Laboratories Inc /de | Vandebroek Sophie V. | Director | Sell | 344 | $420.44 | $144,629.64 | -27.5% | +9.0% | +78.5% | |
| Nov 27, 2024 | RPID Rapid Micro Biosystems, Inc. | Pei Melinda Litherland88 | Director | Buy | 20,000 | $1.05 | $20,998.92 | +69.7% | +184.8% | +323.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.